Hand-Assisted Laparoscopic Nephroureterectomy (HALNU): An Assessment of the Impact of Obesity in 50 Procedures

Brown, James A.; Chenven, Eric S.; Looney, Stephen W.; Miller, Kelly M.; Bagley, Demetrius H.; Gomella, Leonard G.

doi:10.1089/lap.2006.0131

Cited by 6 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study is also the first to associate age, race, ECOG performance status, CKD stage and CCI score as independent predictors of peri‐operative complications. Lastly, similarly to other studies, we also found that BMI was not a factor in operation duration, estimated blood loss and complications rates . Given the rarity of UTUC, it is unlikely that a randomized trial examining peri‐operative outcomes of RNU will be conducted.…”

Section: Discussionsupporting

confidence: 84%

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 84%

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Patients who received neoadjuvant chemotherapy had a significantly higher median BMI than patients who underwent LNUX alone, suggesting that these patients may have been prone to a higher rate of adverse events; however, previous studies have shown that LNUX can be performed without significant differences in operative time, estimated blood loss, or complication rates among groups of patients with BMIs as high as 45. 23 The patients in the current study had estimated blood loss values, operative times, and lengths of hospital stays that were well within the ranges reported in various previous studies .7 , 9 , 13 , 24 , 25 Although the overall complication rates in the current study were higher than those previously reported, previous studies did not use the Clavien system or a similar systematic scale to grade complications; thus, some complications-predominantly those considered to be lower grade-may not have been included in the previous studies' measured rates.…”

Section: Commentmentioning

confidence: 99%

490 Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy

Rajput¹,

Kamat²,

Clavell-Hernández³

et al. 2011

Journal of Urology

View full text Add to dashboard Cite

Objectives-To determine the effect of neoadjuvant chemotherapy on surgical outcomes in patients undergoing laparoscopic radical nephroureterectomy (LNUX) for upper urinary tract urothelial carcinoma (UTUC).Methods-We performed a retrospective review of all UTUC patients who underwent LNUX performed at our institution between January 2003 and June 2010. We compared differences in demographic, clinicopathological, and operative parameters, including estimated blood loss, duration of surgery, length of postoperative hospitalization, and number of complications, between patients who underwent LNUX after neoadjuvant chemotherapy and patients who underwent LNUX without neoadjuvant chemotherapy. Logistic regression analysis was performed to identify predictors of complications.Results-We identified 82 UTUC patients who underwent LNUX; 26 received neoadjuvant chemotherapy. Patients who underwent LNUX after neoadjuvant chemotherapy had a higher body mass index, higher biopsy tumor grade, and longer operative time than patients who underwent LNUX without neoadjuvant chemotherapy. Patients who received neoadjuvant chemotherapy underwent regional lymphadenectomy more often, with more lymph nodes and lymphoadipose tissue removed, than patients who did not receive neoadjuvant chemotherapy. Neoadjuvant chemotherapy resulted in a 15% complete remission rate. No differences in median estimated blood loss, intraoperative transfusions, and length of hospitalization between the two groups were found. Perioperative complication rates were similar in both groups.Conclusions-We found no differences in surgical outcomes between patients who underwent LNUX after neoadjuvant chemotherapy and patients who underwent LNUX without neoadjuvant chemotherapy. Our findings support the use of LNUX in selected patients undergoing neoadjuvant chemotherapy for UTUC.

show abstract

Complications of Minimally Invasive Surgery and Their Management

et al. 2016

View full text Add to dashboard Cite

Minimally invasive surgery, including both traditional laparoscopic and robot-assisted laparoscopic approaches, has increasingly become the standard of care for urologic abdominal and pelvic surgery. This is a comprehensive review of the contemporary literature regarding complications of laparoscopic and robotic urologic surgery. The review highlights pertinent studies with the goal of providing the minimally invasive urologic surgeon with an up-to-date overview of general and procedure-specific complications and their management.

show abstract

Hand-Assisted Laparoscopic Nephroureterectomy (HALNU): An Assessment of the Impact of Obesity in 50 Procedures

Abstract: HALNU is an effective surgical treatment for patients with BMIs as great as 45.

Cited by 6 publications

References 22 publications

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

Preoperative nomogram to predict the likelihood of complications after radical nephroureterectomy

490 Perioperative Outcomes of Laparoscopic Radical Nephroureterectomy and Regional Lymphadenectomy in Patients With Upper Urinary Tract Urothelial Carcinoma After Neoadjuvant Chemotherapy

Complications of Minimally Invasive Surgery and Their Management

Contact Info

Product

Resources

About